Thrombocytosis in a patient with acute promyelocytic leukemia during treatment with all‐trans retinoic acid and arsenic trioxide

Maryam Habibi; Reza Manouchehri Ardekani; Hossein Motedayyen

doi:10.1002/ccr3.3978

Clinical Case Reports (Apr 2021)

Thrombocytosis in a patient with acute promyelocytic leukemia during treatment with all‐trans retinoic acid and arsenic trioxide

Maryam Habibi,
Reza Manouchehri Ardekani,
Hossein Motedayyen

Affiliations

Maryam Habibi: Autoimmune Diseases Research Center Kashan University of Medical Sciences Kashan Iran
Reza Manouchehri Ardekani: Autoimmune Diseases Research Center Kashan University of Medical Sciences Kashan Iran
Hossein Motedayyen: Autoimmune Diseases Research Center Kashan University of Medical Sciences Kashan Iran

DOI: https://doi.org/10.1002/ccr3.3978
Journal volume & issue: Vol. 9, no. 4
pp. 2192 – 2195

Abstract

Read online

Abstract Thrombocytosis is an unusual side effect of all‐trans retinoic acid (ATRA) treatment that occurs in some patients with acute promyelocytic leukemia (APL).

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/20500904

About the journal

Abstract

Keywords